Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Gator, shrimp po’boys made to order, but Chef Esra has more than sandwiches plated for KC’s East Side
Opening a restaurant is just one phase of Esra England’s vision for Kansas City’s East Side. “I’m looking at a restaurant as an anchor point. Once you have a restaurant in the area, the community will be able to do different things like host meetings or classes — and hopefully, other businesses will start to…
KC investors power $4.5M round for OP startup poised to ‘unlock billions’ for its customers
Overland Park-based Realto has closed a $4.5 million funding round — thanks in large part to the backing of Kansas City-based investors. “We’re excited to welcome these important investors as we continue to expand our robust trading capabilities across the universe of alternative products,” Brian King, co-founder and CEO, said in announcement of the funding round which…
Meet seven founders hoping to pay their bills while changing the world; LaunchKC Social Venture Studio unveils first cohort
Dr. Shelley Cooper held back tears during a nearly four-hour introductory session to the new LaunchKC Social Venture Studio earlier this spring, she said. She’d already found her calling with Diversity Telehealth; now the startup founder had discovered truly mission-aligned colleagues within her cohort. “My focus has always been to bring healthcare to underserved areas…
Kauffman anchors $100M fund to boost minority-led ventures, access to capital
Editor’s note: The Ewing Marion Kauffman Foundation is a financial supporter of Startland News. A $100 million fund is expected to help close the wealth gap and better fund BIPOC-led ventures — thanks in part to Kansas City’s own Ewing Marion Kauffman Foundation. Joining forces with Living Cities, the Kauffman Foundation has committed $10 million to…